South Africa provinces face drug 'stock-outs' due to overspending

12 April 2010

As a result of enormous provincial overspends, provinces of South Africa have seen health facilities across the country running out of lifesaving medicines, ranging from hypertension drugs and pediatric vaccinations to tuberculosis and HIV treatment, report Anso Thom and Lungi Langa for Health-e.

New budgets were expected to kick in on April 1, but the situation is dire at many hospitals and clinics, especially those in rural areas. Health-e has received 'stock-out' reports from doctors, nurses and pharmacists in all provinces except the Northern Cape and NorthWest (although this does not mean there are no shortages).

However, provincial media representatives in the Eastern Cape, Free State, KwaZulu-Natal and Gauteng denied that there were any stock outs. Reports from the Eastern Cape detailed stock outs at Thafalofefe, Mthatha General, Cecilia Makiwane, Zithulele and Madwaleni hospitals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical